The WoVen Podcast
Canaan on Twitter
Canaan on LinkedIn
© Copyright 2022 Canaan |
We invest in visionary teams with transformative ideas.
Join Canaan's extended family.
Trishula is a clinical stage company dedicated to the development of TTX-030, a first-in-class, anti-CD39 antibody being studied in advanced cancers in multiple indications.
South San Francisco, CA, USA
Inaccurate data? Flag it here.
Open jobs at Trishula Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their
We only use strictly necessary, first-party cookies on this job board. These are cookies that are necessary to deliver this service to you, or are necessary for Canaan Partners to understand how it is being used. Read our